The British Pharmacopoeia (BP) Draft guidance on replication competent virus assays (from Catapult’s regulatory round-up for December 2024)
The BP has prepared draft best practice guidance on replication competent virus assays. This guidance is intended to ensure product quality is upheld throughout the product’s lifecycle. The deadline for comments is 28th February 2025. The consultation document and response form can be downloaded here.
Published on the 9th of January 2025. Read the entire Regulatory Round-up – December 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (12 février 2025). The British Pharmacopoeia (BP) Draft guidance on replication competent virus assays (from Catapult’s regulatory round-up for December 2024). ELSIBI. Consulté le 17 février 2026 à l’adresse https://doi.org/10.58079/13axw





